Forecast
The analysts' average price target is €75.37 (+28.84%). The median is €71.54 (+22.29%).
| Buy |
15 |
| Hold |
12 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
In the last quarter, CERIDIAN HCM HLDG had revenue of €410.39m and net profit of -€167.7m
| (EUR) | September 2025 | YoY |
|---|---|---|
| Revenue | 410.39m | - |
| Gross profit | 0 | - |
| Net profit | -167.7m | - |
| EBITDA | -86.83m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €9.89bn |
Number of shares | 156.13m |
52-week high/low | €71.98 - €50.69 |
| Dividends | No |
Beta | 1.37 |
P/E ratio | -63.51 |
PEG ratio | 0.17 |
P/B ratio | 4.14 |
P/S ratio | 11.81 |
Company profile
Ceridian HCM Holding Inc., together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market. The company also provides Bureau solutions for payroll and payroll-related services. It sells its solutions through direct sales force and third-party channels. The company was incorporated in 2013 and is headquartered in Minneapolis, Minnesota.
| Name | CERIDIAN HCM HLDG |
| CEO | David D. Ossip |
| Headquarters | Minneapolis,
mn USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Technology |
| IPO | 26/04/2018 |
| Employees | 8,526 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | CDAY |
Düsseldorf | CQL.DU |
Frankfurt | CQL.F |
München | CQL.MU |
Toronto Stock Exchange | CDAY.TO |
NYSE | DAY |